Study title: Neuroblastoma: imaging evaluation by sequential Tc-99m MDP, I-131 MIBG, and Ga-67 citrate studies. Garty I, Friedman A, Sandler MP, Kedar A. Clin Nucl Med. 1989 Jul;14(7):515-22.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Diagnosis [E01] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID | |||||
ATC code: V09BA02 | |||||
Document link: | |||||
Document date: 2014-11-24 | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |